ELITE PHARMACEUTICALS INC /NV/ 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Feb 18, 2016
Insider Transaction Report
Form 4
Ward Carter Julian
Chief Financial Officer
Transactions
- Award
Common Stock
2016-02-16$0.25/sh+122,325$29,994→ 1,085,618 total
Holdings
- 1,355,014(indirect: By IRA)
Common Stock